In human triple-negative breast cancer, inhibition of BAZ2A has been demonstrated to induce apoptosis, while BAZ2A has also been implicated in regulating hypermethylation, contributing to advanced tumor stages and recurrence in prostate cancer [34]. The gene discussed is BAZ2A; the disease is triple-negative breast carcinoma.